Related Experiment Video

Updated: Aug 3, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides

K Moriya1, M Matsukura, K Kurokawa

  • 1First Department of Internal Medicine, University of Tokyo, Japan.

Biochemical and Biophysical Research Communications
|January 5, 1996
PubMed

Insights

Antisense oligodeoxynucleotides targeting the hepatitis B virus HBx gene prevented liver tumors in mice. This approach shows promise for preventing hepatocellular carcinoma in hepatitis B virus infection.

Area of Science:

  • Hepatology
  • Oncology
  • Molecular Biology

Background:

  • Hepatocellular carcinoma (HCC) is a major complication of chronic hepatitis B virus (HBV) infection.
  • Effective therapies to prevent HBV-associated HCC are lacking.
  • Antisense oligodeoxynucleotides (ASOs) offer a potential strategy to inhibit HBV gene expression.

Purpose of the Study:

  • To evaluate the efficacy of antisense phosphorothioate oligodeoxynucleotides (ASOs) in preventing HCC development.
  • To investigate the inhibition of HBV HBx gene expression using ASOs in a mouse model.

Main Methods:

  • A mouse model transgenic for the HBV HBx gene was utilized.
  • Antisense and sense oligodeoxynucleotides targeting the HBx gene initiation codon were synthesized.
  • Mice received intraperitoneal injections of ASOs thrice weekly for 8 weeks.

Main Results:

  • Antisense sequences targeting the HBx gene initiation codon effectively inhibited its expression in the liver.
  • ASO treatment prevented the development of preneoplastic lesions in the liver.
  • No significant liver inflammation or developmental disturbances were observed in the treated mice.

Conclusions:

  • Antisense phosphorothioate oligodeoxynucleotides can successfully inhibit HBV gene expression.
  • This ASO strategy presents a promising therapeutic approach for preventing hepatocellular carcinoma in HBV-infected individuals.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...